DRREDDYlow · TIE-UP
Dr. Reddy's Laboratories Limited has today, i.e., September 18, 2026, entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India Private Limited for Qdenga® in the private market in India.
Dr Reddy's Laboratories · Healthcare · filed 18 Sept, 09:04 IST
Why we say this
The facts in the filing itself.
- Dr. Reddy's Laboratories Limited has today, i.e., September 18, 2026, entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India Private Limited for Qdenga® in the private market in India.
- Filed with NSE on 2026-09-18 under the category "Arrangements for strategic, technical, manufacturing, or marketing tie up". Classified from that category alone — no model and no PDF, because NSE has no category for losing an order or reducing capacity.
What this kind of filing means
About tie-up filings in general.
An agreement to work with another company — manufacturing, distribution, technology. A signed intention, not yet a result.
ExampleMany memoranda of understanding never turn into revenue.
About this kind of filing — not a reading of this one.